spacer
home > about us
Samedan Ltd. Pharmaceutical Publishers

Specialist pharmaceutical publisher Samedan Ltd is a dynamic, forward-thinking company, enjoying year-on-year growth with its five market-leading titles for industry professionals: European Pharmaceutical Contractor, Pharmaceutical Manufacturing and Packing Sourcer, European Biopharmaceutical Review, Innovations in Pharmaceutical Technology, and International Clinical Trials.

In 2013, the company extended its range with the acquisition of the Pharmafile portfolio, consisting of Pharmafocus newspaper, www.pharmafile.com, and Pharmafile directory. The London-based company has been producing a wide range of magazines for the global pharmaceutical arena since 1996, covering a wide range of hot topics including R&D, clinical trials, cutting-edge technology, manufacture, packaging, logistics, regulations, and industry insight.

Located in an idyllic region synonymous with culture and quality, the Alpine village of Samedan is renowned for its tradition of hospitality and shares many of its ideals with the company it inspired. Samedan hopes to develop its ties with the industry further still and maintains a fresh vision for the future.

spacer

Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

News and Press Releases

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with the NASDAQ listed biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the company’s unique formulations using its proprietary in vitro models to optimise Novan’s formulations and de-risk product development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement